GGrantIndex
Sort

39,280 grants matching leukemia

Molecular Pathogenesis of Acute Myeloid Leukemia

$944,000
Timothy J Ley · Washington University · R35 · FY2022 · CA

Hematopoietic Stem Cell Transplant for GATA2 Deficiency

$943,547
Dennis Hickstein · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Multidrug resistance Mediated by P-glycoprotein

$943,099
Antonio Fojo · Clinical Sciences · Z01 · FY2007 · CA

Development of Novel Therapies for Acute Lymphoblastic Leukemia

$943,000
Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Oligodendroglial Interactions Group

$942,488
Tobias Merson · National Institute Of Mental Health · ZIA · FY2023 · MH

Optimizing the graft versus leukemia effect for pediatric ALL

$942,362
Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system

$942,313
Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action

$942,313
Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Exploiting synthetic lethality of hematopoietic lineage cells to develop novel ta

$941,894
Kyle Russell Bonneau · Cellecta, Inc. · R44 · FY2011 · CA

Mechanism and therapeutic implication of RNA-modification-mediated codon-biased translation in acute myeloid leukemia

$941,798
Jianjun Chen · Beckman Research Institute/City Of Hope · U01 · FY2025 · CA

Office of Cancer Genomics

$941,752
Douglas R. Lowy · Office Of The Director, Nci · ZIA · FY2010 · CA

Role of 11q23 Chromosome Abnormalities in the Causation of Acute Leukemia

$940,999
Carlo M Croce · Ohio State University · P01 · FY2011 · CA

Translating genomic discoveries to improved outcomes for high risk acute leukemia

$940,706
Charles G. Mullighan · St. Jude Children'S Research Hospital · R35 · FY2020 · CA

Molecular strategies for early detection and targeting of cancer

$940,702
Tannishtha Reya · Columbia University Health Sciences · R35 · FY2023 · CA

Clinical Research Core

$940,513
Michael Keating · University Of California, San Diego · P01 · FY2008 · CA

MOLECULAR TAXONOMY OF PEDIATRIC AND ADULT ACUTE LEUKEMIA

$940,468
University Of New Mexico · U01 · FY2002 · CA

Prevalence and persistence of the ETV6/RUNX1 pre-leukemic clone

$940,391
Erin Marcotte · University Of Minnesota · R01 · FY2023 · CA

Novel methods to improve nuclease mediated homologous recombination

$940,327
Jifeng Zhang · Atgc, Inc. · R42 · FY2023 · GM

Novel signaling molecules regulating platelet activation

$940,028
Satya P. Kunapuli · Temple Univ Of The Commonwealth · R35 · FY2022 · HL

BioRad Galactomannan EIA for Diagnosis of Aspergillosis

$939,437
Fred Hutchinson Cancer Research Center · U01 · FY2003 · AI

Translational Development of Replication-Competent Retrovirus Vectors

$939,203
Noriyuki Kasahara · University Of California Los Angeles · U01 · FY2012 · NS

Molecular strategies for early detection and targeting of cancer

$938,926
Tannishtha Reya · Columbia University Health Sciences · R35 · FY2024 · CA

Wee1 and HDAC inhibition in relapsed/refractory AML

$938,670
Steven Grant · Virginia Commonwealth University · UH2 · FY2015 · TR

Illinois Oncology Research Association CCOP

$938,655
John W Kugler · Oncology-Hematology Assoc-Central Ill · U10 · FY2008 · CA

High throughput CAR-T potency assay based on functional and transcriptional measurements on single cell co-cultures

$938,647
Benjamin Biron Yellen · Celldom, Inc. · R44 · FY2024 · CA